Teva Reports First Quarter 2020 Financial Results | Business Wire
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Teva puts further $468m aside for opioid settlements | Financial Times
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva shares surge after announcing global opioid settlement
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Finds Relief In US Opioid Crisis Settlement, Updates Long-Term Objectives :: Scrip
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
The Collapse of Teva, the Israeli giant generic drug company – a case study in strategy and intelligence
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
